Work

Phase IIa study of αDC1 vaccines targeting HER2/HER3 combined with pembrolizumab in patients with asymptomatic brain metastasis from breast cancer.

Year: 2025

Type: article

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2025.43.16_suppl.tps2088

Authors: Shipra Gandhi, Peter A. J. Forsyth, Mateusz Opyrchal, Audrey Rawleigh, Matthew Sydor, Kamran A. Ahmed, Kristopher Attwood, Patrick Michael Dillon, Camilo E. Fadul, Dheerendra Prasad, Sheheryar Kairas Kabraji, Ellis Glenn Levine, Kevin Kalinsky, Brian J. Czerniecki, Pawel Kalinski

Institutions: Roswell Park Comprehensive Cancer Center, Moffitt Cancer Center, Indiana University Indianapolis, University of Virginia, Winship Cancer Institute

Language: English

Topic: Brain Metastases and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: U.S. Department of Defense

OpenAlex ID: W4410818803

FWCI: 0.587

Cites:

Cited by: 1

Related to: 10